Book Publishing in the Pandemic
In this informal conversation, several authors whose books came out in the past year share their experiences with book marketing in the time of pandemic.
In this informal conversation, several authors whose books came out in the past year share their experiences with book marketing in the time of pandemic.
Join us for an informal chat with a representative from Dinghy insurance about professional liability insurance. Come with questions! Dinghy has partnered with the Freelancers Union and is trying to fill a niche for freelancers/creatives who need or want some coverage but want the cost to be reasonable.
NASW members are invited to apply for a spot in the Peggy Girshman Idea Grant-funded workshop "Pandemic Recovery: Creativity, Mental Health and Resilience."
Given the continuing risks and uncertainties posed by the coronavirus pandemic, ScienceWriters2021 (#SciWri21) will be held as a virtual-only event. The decision was reached in coordination with our hosting partners at the University of Colorado Boulder and University of Colorado Anschutz Medical Campus.
Join the National Press Club Journalism Institute and the National Association of Science Writers for Numbers are not neutral: How journalists can detect deep bias & avoid hidden traps.
Please join us on Wednesday, May 26 at 6 p.m. Eastern Time for a Zoom happy hour event to get to know some of our Latin American science communication colleagues.
Join the Video Consortium and the National Association of Science Writers as we explore an exciting new chapter in science, media, and video innovation. Our event will explore the evolution of science video, from NOVA to YouTube to TikTok, and how three expert creators are thriving in a competitive world of facts, narrative innovation and visual creativity.
Seattle’s UW Medicine Virology Lab has been at the forefront of the fight against the coronavirus pandemic since its beginnings in the U.S. The lab developed its own test for COVID-19, assessed potential therapeutics such as hydroxychloroquine, and is now beginning a project to test 7,000 people repeatedly for the virus and antibodies. This tour will provide a rare inside look at a lab that's typically off limits to visitors due to biohazard concerns.